Study finds weight loss results drive continued Ozempic use despite nausea and other side effects, based on real world ...

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors. Although rare, semaglutide initiation can lead to ...

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.

By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label for weight loss, despite side effects like nausea, diarrhea, and abdominal ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side ...

Find Tirzepatide Side Effects Latest News, Videos & Pictures on Tirzepatide Side Effects and see latest updates, news, information from NDTV.COM. Explore more on Tirzepatide Side Effects.

"December [2025] was a rough month, let me tell you," the 46-year-old shared in a new interview, clarifying that she is "good now." ...

GLP-1 receptor agonists, originally developed for type 2 diabetes, are now witnessing soaring demand for weight management, with drugs like Ozempic gaining widespread popularity, particularly on ...

An AI-designed obesity drug targeting the GIP receptor shows over 31% weight loss in preclinical tests, raising hopes for next-generation metabolic treatments beyond GLP-1 drugs.